Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study

Nick van Boven; Martijn Akkerhuis; Sharda Anroedh; Dimitris Rizopoulos; Y Pinto; Linda Battes; HL Hillege; Kadir Caliskan; T Germans; Olivier Manintveld; JH Cornel; Alina Constantinescu; Eric Boersma; VA Umans; Isabella Kardys

doi:10.1016/j.ijcard.2017.02.078

Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study

Nick van Boven, Martijn Akkerhuis, Sharda Anroedh, Dimitris Rizopoulos, Y Pinto, Linda Battes, HL Hillege, Kadir Caliskan, T Germans, Olivier Manintveld, JH Cornel, Alina Constantinescu, Eric Boersma, VA Umans, Isabella Kardys

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

5 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	124-132
Number of pages	9
Journal	International Journal of Cardiology
Volume	235
DOIs	https://doi.org/10.1016/j.ijcard.2017.02.078
Publication status	Published - 2017

Access to Document

10.1016/j.ijcard.2017.02.078

REPUB_98355_OA.pdfFinal published version, 646 KB

http://hdl.handle.net/1765/98355

Cite this

van Boven, N., Akkerhuis, M., Anroedh, S., Rizopoulos, D., Pinto, Y., Battes, L., Hillege, HL., Caliskan, K., Germans, T., Manintveld, O., Cornel, JH., Constantinescu, A., Boersma, E., Umans, VA., & Kardys, I. (2017). Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study. International Journal of Cardiology, 235, 124-132. https://doi.org/10.1016/j.ijcard.2017.02.078

@article{da86fb1aa150427890c456c0904b8750,

title = "Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study",

author = "{van Boven}, Nick and Martijn Akkerhuis and Sharda Anroedh and Dimitris Rizopoulos and Y Pinto and Linda Battes and HL Hillege and Kadir Caliskan and T Germans and Olivier Manintveld and JH Cornel and Alina Constantinescu and Eric Boersma and VA Umans and Isabella Kardys",

year = "2017",

doi = "10.1016/j.ijcard.2017.02.078",

language = "Undefined/Unknown",

volume = "235",

pages = "124--132",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

van Boven, N , Akkerhuis, M, Anroedh, S, Rizopoulos, D, Pinto, Y, Battes, L, Hillege, HL, Caliskan, K, Germans, T, Manintveld, O, Cornel, JH, Constantinescu, A , Boersma, E, Umans, VA & Kardys, I 2017, 'Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study', International Journal of Cardiology, vol. 235, pp. 124-132. https://doi.org/10.1016/j.ijcard.2017.02.078

TY - JOUR

T1 - Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study

AU - van Boven, Nick

AU - Akkerhuis, Martijn

AU - Anroedh, Sharda

AU - Rizopoulos, Dimitris

AU - Pinto, Y

AU - Battes, Linda

AU - Hillege, HL

AU - Caliskan, Kadir

AU - Germans, T

AU - Manintveld, Olivier

AU - Cornel, JH

AU - Constantinescu, Alina

AU - Boersma, Eric

AU - Umans, VA

AU - Kardys, Isabella

PY - 2017

Y1 - 2017

U2 - 10.1016/j.ijcard.2017.02.078

DO - 10.1016/j.ijcard.2017.02.078

M3 - Article

SN - 0167-5273

VL - 235

SP - 124

EP - 132

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -